Our Purpose
Chronic Liver Disease (CLD) is one of the most common causes of mortality and morbidity worldwide. The most common causes of liver disease include viral hepatitis (hepatitis B, C and D), alcohol related liver disease, non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction Associated Steatotic Liver Disease (MASLD) and autoimmune liver disease such as primary biliary cholangitis (PBC). In order to understand the global impact of CLD, The Global Liver Council (GLC) was created to include renowned experts from different regions of the world with interest in these liver diseases to collaborate and exchange their views. GLC also collaborate with Global NASH Council (GNC) which include over 256 experts from 60 countries. Members of the Council carry out collaborative projects to better understand the burden of CLD across the world. Mission, Vision and Values
About UsThe Global Liver Council™
The Global Liver Council ™ has been formed to bring together international experts to discuss, collaborate and contribute to the field of viral hepatitis, alcohol related liver disease and primary biliary cholangitis. Given the global nature of CLDs and their distribution in different regions of the world, it is important to include perspectives from different perspectives, assess the clinical and economic impact of CLD which are based on the realities of each country and region. The Global Liver Council ™ communicate through several Web-meetings or in person meetings when needed. The in-person meetings are designed to discuss new topics in specific areas of CLD (such as HDV, PBC etc) and design joint projects that will contribute to the understanding of CLD. The Council members also form selected collaborative teams to address specific issues such as region-specific PRO impact of ALD and PBC. Most members of the Global Liver Council ™ are also active participating sites for the Global Liver Registry ™.
Learn More
The Global Liver Registries
The Global Liver Registry™ is a collaborative effort led by members of the GLC and GNC. These Registries are developed to collect clinical data, laboratory data and PRO data for patients with NASH/NAFLD or MASH/MASLD, HBV , HCV, HDV, PBC, and ALD from different regions of the world. Inclusion into these Registries requires collection of the data after informed consent. Data is entered through secure cloud platform into a central secured database managed by the data management team. The information in the Registries is completely de-identified and HIPAA compliant. These Registries include sites from North America, Europe, Asia, Middle East, North Africa and Australia. The ultimate goals of these registries are to obtain real world clinical and PRO data about patients with the most common causes of liver disease from different regions of the world. This data will inform us about the similarities and differences of these important liver diseases across the globe.
Learn More